Atıf Formatları
Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Z. NARLI ÖZDEMİR Et Al. , "Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response," Hematological Disease and Therapies , 2018

NARLI ÖZDEMİR, Z. Et Al. 2018. Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response. Hematological Disease and Therapies .

NARLI ÖZDEMİR, Z., USLU, A., TOPRAK, S. K., TOPÇUOĞLU, P., DALVA, K., & İLHAN, O., (2018). Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response. Hematological Disease and Therapies .

NARLI ÖZDEMİR, ZEHRA Et Al. "Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response," Hematological Disease and Therapies , 2018

NARLI ÖZDEMİR, ZEHRA N. Et Al. "Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response." Hematological Disease and Therapies , 2018

NARLI ÖZDEMİR, Z. Et Al. (2018) . "Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response." Hematological Disease and Therapies .

@article{article, author={ZEHRA NARLI ÖZDEMİR Et Al. }, title={Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response}, journal={Hematological Disease and Therapies}, year=2018}